Insight

Big step forward in improving the care and quality of care for patients – EGFR Positive UK

Photo taken from cen.acs.org

Jul 8, 2024, 10:22

Big step forward in improving the care and quality of care for patients – EGFR Positive UK

EGFR Positive UK made the following post on X:

“Study finds liquid biopsies are as reliable as tissue biopsies for lung cancer pts with EGFR mutations, but far less invasive, making it easier to monitor & tailor treatments effectively. This is a big step forward in improving the care & QOL for patients.”

Big step forward in improving the care and quality of care for patients - EGFR Positive UK

Luis E. Raez, Medical Director at Memorial Cancer Institute, retweeted this post, adding the following:

“These are great news! several of us have shown before that we can use liquid biopsies first
to make treatment decisions faster for our patients.”

Read further.
Source: EGFR Positive UK/X and Luis E. Raez/X

cancer cancer monitoring cancer treatment EGFR Mutations EGFR Positive UK liquid biopsy Luis E. Raez Lung cancer Memorial Cancer Institute non-invasive testing OncoDaily Oncology patient care personalized medicine quality of life tissue biopsy

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage